Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone49-6172-6080
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$39.40 billion
Profitability
Miscellaneous
Employees283,795
Next Earnings Date8/28/2019 (Estimated)
OptionableNot Optionable
FRESENIUS SE &/S (OTCMKTS:FSNUY) Frequently Asked Questions
What is FRESENIUS SE &/S's stock symbol?
FRESENIUS SE &/S trades on the OTCMKTS under the ticker symbol "FSNUY."
How often does FRESENIUS SE &/S pay dividends? What is the dividend yield for FRESENIUS SE &/S?
FRESENIUS SE &/S announced an annual dividend on Monday, April 8th. Investors of record on Tuesday, May 21st will be paid a dividend of $0.15 per share on Thursday, May 30th. This represents a yield of 1.03%. The ex-dividend date is Monday, May 20th. View FRESENIUS SE &/S's Dividend History.
When is FRESENIUS SE &/S's next earnings date?
What is the consensus analysts' recommendation for FRESENIUS SE &/S?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FRESENIUS SE &/S in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for FRESENIUS SE &/S.
Has FRESENIUS SE &/S been receiving favorable news coverage?
News headlines about FSNUY stock have trended positive this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. FRESENIUS SE &/S earned a coverage optimism score of 2.5 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next few days. View News Stories for FRESENIUS SE &/S.
Who are some of FRESENIUS SE &/S's key competitors?
Some companies that are related to FRESENIUS SE &/S include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Novocure (NVCR), Insulet (PODD), ABIOMED (ABMD), Hill-Rom (HRC), Haemonetics (HAE), Integra Lifesciences (IART) and Globus Medical (GMED).
What other stocks do shareholders of FRESENIUS SE &/S own?
Who are FRESENIUS SE &/S's key executives?
FRESENIUS SE &/S's management team includes the folowing people:
- Mr. Stephan Sturm, CEO & Chairman of Management Board - Fresenius Management SE (Age 56)
- Ms. Rachel Clare Empey, CFO & Member of Management Board - Fresenius Management SE (Age 43)
- Dr. Francesco De Meo, Member of Management Board - Fresenius Management SE (Age 55)
- Dr. Jürgen Götz, Chief Legal & Compliance Officer & Labor Relations Director and Member of Management Board - GP (Age 55)
- Dr. Ernst Wastler, Member of Management Board - Fresenius Management SE (Age 60)
How do I buy shares of FRESENIUS SE &/S?
Shares of FSNUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is FRESENIUS SE &/S's stock price today?
One share of FSNUY stock can currently be purchased for approximately $12.17.
How big of a company is FRESENIUS SE &/S?
FRESENIUS SE &/S has a market capitalization of $27.11 billion and generates $39.40 billion in revenue each year. The company earns $2.39 billion in net income (profit) each year or $0.79 on an earnings per share basis. FRESENIUS SE &/S employs 283,795 workers across the globe.View Additional Information About FRESENIUS SE &/S.
What is FRESENIUS SE &/S's official website?
How can I contact FRESENIUS SE &/S?
FRESENIUS SE &/S's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The company can be reached via phone at 49-6172-6080 or via email at [email protected]
MarketBeat Community Rating for FRESENIUS SE &/S (OTCMKTS FSNUY)
MarketBeat's community ratings are surveys of what our community members think about FRESENIUS SE &/S and other stocks. Vote "Outperform" if you believe FSNUY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FSNUY will underperform the S&P 500 over the long term. You may vote once every thirty days.
